A Novel Highly Potent Therapeutic Antibody Neutralizes Multiple Human Chemokines and Mimics Viral Immune Modulation

PLoS ONE - United States
doi 10.1371/journal.pone.0043332
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Cancer Research
Cancer ResearchOncology
2016English

Highly Potent, Fully Recombinant Anti-Hiv Chemokines: Reengineering a Low-Cost Microbicide

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

FPL 66096: A Novel, Highly Potent and Selective Antagonist at Human Platelet P2t-Purinoceptors

British Journal of Pharmacology
Pharmacology
1994English

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and in Vivo Evidence

Clinical Cancer Research
Cancer ResearchOncology
2012English

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Current Drug Target -Inflammation & Allergy
2004English

Potent Binding of 2019 Novel Coronavirus Spike Protein by a SARS Coronavirus-Specific Human Monoclonal Antibody

2020English

AZD9773 Is a Novel and Potent Anti-TNFα Polyclonal Ovine Immune Fab

Critical Care
Critical CareIntensive Care Medicine
2011English

Serrumab: A Novel Human Single Chain-Fragment Antibody With Multiple Scorpion Toxin-Neutralizing Capacities

Journal of Immunotoxicology
ToxicologyImmunology
2013English

Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?

Mediators of Inflammation
ImmunologyCell Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy